drugset / Trial / NCT06207877
A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body Weight
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This research study tests if CagriSema influences food intake, appetite and emptying of the stomach in people with excess body weight. Participant will either get CagriSema (active medicine) or placebo (a dummy medicine), which has no effect on the body. The treatment participants get is decided by chance. The study will last for about 32 weeks.
Timeline
- Start
- 2024-02-23
- Primary completion
- 2024-10-16
- Completion
- 2024-11-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cagrilintide | Protein / enzyme biologic | — | Subcutaneous |
| Subject | Semaglutide | Peptide | — | Subcutaneous |